Talk:George Kollias (biologist)

message: George Kollias, PhD,Brief CV at Alexander Fleming BSRC is President and Scientific Director of Alexander Fleming BSRC . He obtained his BSc and his PhD from the University of Athens, Greece. He was a postdoctoral fellow at the National Institute for Medical Research in London UK (1985–1987). He was the Head of the Laboratory of Molecular Genetics at the Hellenic Pasteur Institute in Athens, Greece, (1989–2000) and the Director of Institute for Immunology at FLM (2000–2002). Dr Kollias is an EMBO member. He has a long record in the generation and characterization of animal models of human diseases Kollias is a distinguished scientist with an H-index over 50.
Dr. George Kollias, is a leading scientist in the field of TNF function in pathophysiology, highly reputed for establishing and characterizing disease pathways in animal models of chronic inflammation and autoimmunity (e.g. Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, endotoxic shock and systemic lupus). His group was first to provide in vivo, proof of principle studies, on deregulated TNF production being causal to the development of chronic polyarthritis in a transgenic animal model, and for showing originally that anti-TNF antibody treatment was efficacious in treating the modelled disease [Author]. These studies were instrumental in mobilizing the interest of anti-TNF industry in rheumatoid arthritis and foreshadowed the success of the first clinical trials performed. Recent studies on the expression signature of the arthritogenic synovial fibroblast led to the identification and functional validation in relevant animal models of cytoskeletal rearrangements as a novel pathophysiological determinant in inflammatory joint disease. These studies have created a unique list of disease modifiers of potential therapeutic value. Dr. Kollias research is supported by several competitive grants from the European Commission and National sources, as well as by the international biopharmaceutical industry. Dr. Kollias was appointed Coordinator of a consortium of 24 European organizations constituting a Network of Excellence on ‘Functional Genomics in mutant mouse models as tools to investigate the complexity of human immunological disease’ [6th Framework Program (2005-2009) – 11M€] .<ref>MUGEN NoE participants. Dr. Kollias serves as an advisor for scientific organizations and consults for industry. He is also a reviewer for high-impact scientific Journals and evaluator for European Commission, National and International project and was recently elected and currently serves as President of the Council of the Directors of the Greek Research Centers (2009-2010).
Kanei22 (talk) 18:06, 14 January 2011 (UTC)
thread_title:  Edit request from Kanei22, 14 January 2011 

message: George Kollias, PhD,Brief CV at Alexander Fleming BSRC is President and Scientific Director of Alexander Fleming BSRC . He obtained his BSc and his PhD from the University of Athens, Greece. He was a postdoctoral fellow at the National Institute for Medical Research in London UK (1985–1987). He was the Head of the Laboratory of Molecular Genetics at the Hellenic Pasteur Institute in Athens, Greece, (1989–2000) and the Director of Institute for Immunology at FLM (2000–2002). Dr Kollias is an EMBO member. He has a long record in the generation and characterization of animal models of human diseases Kollias is a distinguished scientist with an H-index over 50.
Dr. George Kollias, is a leading scientist in the field of TNF function in pathophysiology, highly reputed for establishing and characterizing disease pathways in animal models of chronic inflammation and autoimmunity (e.g. Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, endotoxic shock and systemic lupus). His group was first to provide in vivo, proof of principle studies, on deregulated TNF production being causal to the development of chronic polyarthritis in a transgenic animal model, and for showing originally that anti-TNF antibody treatment was efficacious in treating the modelled disease [Author]. These studies were instrumental in mobilizing the interest of anti-TNF industry in rheumatoid arthritis and foreshadowed the success of the first clinical trials performed. Recent studies on the expression signature of the arthritogenic synovial fibroblast led to the identification and functional validation in relevant animal models of cytoskeletal rearrangements as a novel pathophysiological determinant in inflammatory joint disease. These studies have created a unique list of disease modifiers of potential therapeutic value. Dr. Kollias research is supported by several competitive grants from the European Commission and National sources, as well as by the international biopharmaceutical industry. Dr. Kollias was appointed Coordinator of a consortium of 24 European organizations constituting a Network of Excellence on ‘Functional Genomics in mutant mouse models as tools to investigate the complexity of human immunological disease’ [6th Framework Program (2005-2009) – 11M€] .<ref>MUGEN NoE participants. Dr. Kollias serves as an advisor for scientific organizations and consults for industry. He is also a reviewer for high-impact scientific Journals and evaluator for European Commission, National and International project and was recently elected and currently serves as President of the Council of the Directors of the Greek Research Centers (2009-2010).
Kanei22 (talk) 18:06, 14 January 2011 (UTC)
replies: text: Not done: please provide reliable sources that support the change you want to be made. --Darkwind (talk) 03:41, 17 January 2011 (UTC)
thread_title:  Edit request from Kanei22, 14 January 2011 

message: Hello fellow Wikipedians,
I have just modified one external link on George Kollias (biologist). Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
*Added archive https://web.archive.org/web/20110709012857/http://www.nimr.mrc.ac.uk/ to http://www.nimr.mrc.ac.uk/
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
Cheers.—InternetArchiveBot (Report bug) 20:07, 13 October 2017 (UTC)
thread_title:  External links modified